213 related articles for article (PubMed ID: 35467371)
1. Penicillin- and Ciprofloxacin-Resistant Invasive Neisseria meningitidis Isolates from Japan.
Saito R; Nakajima J; Prah I; Morita M; Mahazu S; Ota Y; Kobayashi A; Tohda S; Kamiya H; Takahashi H; Ohnishi M
Microbiol Spectr; 2022 Jun; 10(3):e0062722. PubMed ID: 35467371
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistance among invasive Neisseria meningitidis isolates in England, Wales and Northern Ireland (2010/11 to 2018/19).
Willerton L; Lucidarme J; Walker A; Lekshmi A; Clark SA; Walsh L; Bai X; Lee-Jones L; Borrow R
PLoS One; 2021; 16(11):e0260677. PubMed ID: 34843604
[TBL] [Abstract][Full Text] [Related]
3. Emergence of ciprofloxacin- and penicillin-resistant
Takahashi H; Morita M; Kamiya H; Fukusumi M; Yasuda M; Sunagawa M; Nakamura-Miwa H; Ohama Y; Shimuta K; Ohnishi M; Saito R; Akeda Y
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0074423. PubMed ID: 37874301
[TBL] [Abstract][Full Text] [Related]
4. Invasive meningococcal disease due to ciprofloxacin-resistant Neisseria meningitidis sequence type 4821: The first case in Japan.
Kawasaki Y; Matsubara K; Takahashi H; Morita M; Ohnishi M; Hori M; Isome K; Iwata A; Nigami H; Ikemachi M; Yamamoto G; Ohkusu K
J Infect Chemother; 2018 Apr; 24(4):305-308. PubMed ID: 29233459
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Susceptibility Survey of Invasive Neisseria meningitidis, United States 2012-2016.
Potts CC; Rodriguez-Rivera LD; Retchless AC; Hu F; Marjuki H; Blain AE; McNamara LA; Wang X
J Infect Dis; 2022 Jun; 225(11):1871-1875. PubMed ID: 35266516
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of antimicrobial resistance in Neisseria meningitidis strains isolated from invasive cases in Brazil from 2009 to 2016.
Gorla MC; Pinhata JMW; Dias UJ; de Moraes C; Lemos AP
J Med Microbiol; 2018 Jun; 67(6):750-756. PubMed ID: 29717974
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of Ciprofloxacin Resistance Among an Expanding Clade of β-Lactamase-Positive, Serogroup Y Neisseria meningitidis in the United States.
Potts CC; Retchless AC; McNamara LA; Marasini D; Reese N; Swint S; Hu F; Sharma S; Blain AE; Lonsway D; Karlsson M; Hariri S; Fox LM; Wang X;
Clin Infect Dis; 2021 Oct; 73(7):1185-1193. PubMed ID: 33900407
[TBL] [Abstract][Full Text] [Related]
8. Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017-19.
Marín JEO; Villatoro E; Luna MJ; Barrientos AM; Mendoza E; Lemos APS; Camargo CH; Sacchi CT; Cunha MPV; Galas M; Gabastou JM
J Antimicrob Chemother; 2021 Apr; 76(5):1155-1159. PubMed ID: 33517418
[TBL] [Abstract][Full Text] [Related]
9. Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance - United States, 2024.
Berry I; Rubis AB; Howie RL; Sharma S; Marasini D; Marjuki H; Crowe S; McNamara LA
MMWR Morb Mortal Wkly Rep; 2024 Feb; 73(5):99-103. PubMed ID: 38329923
[TBL] [Abstract][Full Text] [Related]
10. Australian Meningococcal Surveillance Programme annual report, 2019.
Lahra MM; Hogan TR;
Commun Dis Intell (2018); 2020 Aug; 44():. PubMed ID: 32829701
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
Blondeau JM; Yaschuk Y
Antimicrob Agents Chemother; 1995 Nov; 39(11):2577-9. PubMed ID: 8585750
[TBL] [Abstract][Full Text] [Related]
12. Emergence of ciprofloxacin-resistant
Juscamayta-López E; Valdivia F; Morales S; Donaires LF; Fiestas-Solórzano V; Oré M; Pachas P; León-Janampa N; Gavilán R
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33196407
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and serogroup changes of Neisseria meningitidis in South Korea, 2010-2016.
Lee H; Seo Y; Kim KH; Lee K; Choe KW
Sci Rep; 2018 Mar; 8(1):5292. PubMed ID: 29593277
[TBL] [Abstract][Full Text] [Related]
14. Australian Meningococcal Surveillance Programme annual report, 2013.
Lahra MM; Enriquez RP
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E301-8. PubMed ID: 25631592
[TBL] [Abstract][Full Text] [Related]
15. Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994-1999.
Tapsall JW; Shultz T; Limnios E; Munro R; Mercer J; Porritt R; Griffith J; Hogg G; Lum G; Lawrence A; Hansman D; Collignon P; Southwell P; Ott K; Gardam M; Richardson CJ; Bates J; Murphy D; Smith H;
Pathology; 2001 Aug; 33(3):359-61. PubMed ID: 11523940
[TBL] [Abstract][Full Text] [Related]
16. Emergence of resistance to ciprofloxacin in Neisseria meningitidis in Brazil.
Gorla MC; Cassiolato AP; Pinhata JMW; de Moraes C; Corso A; Gagetti P; Lemos AP
J Med Microbiol; 2018 Mar; 67(3):286-288. PubMed ID: 29458676
[TBL] [Abstract][Full Text] [Related]
17. Demographic Features of Invasive Meningococcal Disease in Taiwan, 1993 to 2020, and Genetic Characteristics of Neisseria meningitidis Isolates, 2003 to 2020.
Chiou CS; Liao YS; Chen BH; Lu MC; Hong YP; Wang YW; Teng RH
Microbiol Spectr; 2022 Aug; 10(4):e0088222. PubMed ID: 35862973
[TBL] [Abstract][Full Text] [Related]
18. A mismatch amplification mutation assay for specific detection of ciprofloxacin-resistant Neisseria meningitidis.
Ota Y; Okada R; Takahashi H; Saito R
J Infect Chemother; 2023 May; 29(5):562-564. PubMed ID: 36758676
[TBL] [Abstract][Full Text] [Related]
19. Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020.
McNamara LA; Potts C; Blain AE; Retchless AC; Reese N; Swint S; Lonsway D; Karlsson M; Lunquest K; Sweitzer JJ; Wang X; Hariri S; Fox LM;
MMWR Morb Mortal Wkly Rep; 2020 Jun; 69(24):735-739. PubMed ID: 32555137
[TBL] [Abstract][Full Text] [Related]
20. Australian Meningococcal Surveillance Programme annual report, 2018.
Lahra MM; Enriquez RP; Hogan TP;
Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
